INTRODUCTION
Homo-or heterodimeric transcription factors with basic region-leucine zipper structure, including Jun, Fos, ATF, and Maf subfamilies, regulate transcription of activator protein (AP)-1-responsive genes in a DNA sequence-specific manner. c-Jun encodes a critical component of the AP-1 transcription factor complex. Proliferative signals induce expression of both c-Fos and c-Jun (Karin et al., 1997; Schreiber et al., 1999) . Mice genetically engineered to abolish either c-Jun or c-Jun NH 2 -terminal kinase (JNK) activity results in embryonic lethality (Jochum et al., 2001) . Of the four mitogenactivated protein kinase (MAPK) subfamilies, c-Jun activity is regulated primarily by Jun kinase (Morton et al., 2003) . The abundance of c-Jun is regulated by transcriptional induction and subsequent degradation through ubiquitination Treier et al., 1994; Fuchs et al., 1996; Musti et al., 1997) .
The c-Jun protein structure consists of multiple functional domains, including an amino-terminal transactivation domain, a regulatory (␦ domain), a carboxy-terminal basic DNA binding domain, and a leucine zipper protein dimerization domain. The ␦ domain is critical for transcriptional activation by c-Jun. One of the first reported functions of the ␦ domain was its engagement of cell type-specific inhibitors of c-Jun (Bohmann and Tjian, 1989; Baichwal and Tjian, 1990; Baichwal et al., 1991) . JNK docks to c-Jun on residues within the ␦ domain (Kallunki et al., 1995 (Kallunki et al., , 1996 . Phosphorylation of c-Jun is thought to facilitate interaction of the c-Jun/AP-1 complex with coactivators. Transcriptional coactivators encoding histone acetyl transferase (HAT) activity, such as the CREB-binding protein (CBP) coactivator, bind to c-Jun facilitating the interaction between the AP-1 complex and the basal transcriptional machinery (Mayr and Montminy, 2001) . JNK-mediated phosphorylation also accelerates c-Jun degradation by allowing recognition of the E3 ligase from the Fbw 7-containing Skp/Culin/F-box protein complex. In addition, JNK enhances activity of the E3 ligase, promoting degradation of c-Jun and JunB (Gao et al., 2004; Nateri et al., 2004) .
c-Jun contributes to contact-independent growth and is essential for the development of chemically induced tumors in mice . Both cellular Jun (c-Jun) and viral Jun (v-Jun) induce oncogenic transformation (Vogt, 2001) . The retrovirally transduced allele of c-Jun, v-Jun, induces fibrosarcoma in chickens (for review, see Vogt, 2001 ). Oncogenic v-jun encodes a protein with complete deletion of the ␦ domain and fails to bind JNK. The role of the ␦ domain itself versus JNK phosphorylation sites within the ␦ domain, in cell cycle control, cellular proliferation, and oncogenesis is complex. Although c-Jun promotes G 1 /S phase progression independently of its phosphorylation status (Wisdom et al., 1999) , c-Jun phosphorylation of serines 63 and 73 were required for Ha-Ras-induced cellular transformation in some , but not all studies (Kennedy et al., 2003) . Finally, although point mutation analysis demonstrated the oncogenic effects of the ␦ domain deletion can be uncoupled from JNK signaling (Sprowles and Wisdom, 2003) , mice and cells harboring a mutant allele of c-jun show reduced tumorigenesis by activated Ras signaling (Bannister et al., 1991) .
A variety of mechanisms attenuate c-Jun-mediated activity (Schutte et al., 1989) . Factors regulating c-jun stability inhibit c-Jun function through reducing its abundance. These factors include macrophage migration inhibitory factor (MIF) (Kleemann et al., 2000) , E3 ligase Fbw 7-containing Skp/Culin/F-box protein complex (SCF Fbw ) (Gao et al., 2004) , and the E3 ligase Itch (Nateri et al., 2004) . Jab1 association with MIF inhibits Jab1-mediated AP-1 activity. Thus, the cytokine MIF serves to transduce cytokine signaling to nuclear c-Jun function. Components of the AP-1 complex itself can inhibit c-Jun activity. The AP-1 transcription factor family is composed of Jun, Fos, and ATF subunits, which interact through their leucine zipper motif and bind DNA through a basic region. Jun proteins form homo-and heterodimers. Several other basic proteins heterodimerize with c-Jun, including Maf (v-Maf, c-Maf, MafB, MafG, and MafK) proteins and the neural retina leucine zipper gene product 1 (Nr1), which may thereby regulate the activity of c-Jun . Finally, c-Jun-binding repressor proteins have been described. The c-Jun-interacting proteins JDP1 and JDP2 regulate UV-mediated apoptosis (Piu et al., 2001) . Recent genome-wide interrogation identified an inhibitor of AP-1-responsive target genes as the DACH1 gene, which is known to be involved in compound eye development (Wu et al., 2003) .
Development of the compound eye in Drosophila is governed by a regulatory network of genes. The eyeless, sine oculis, eyes absent, and dachshund genes are required for normal eye development, and ectopic expression of eyeless, eyes absent, and dachshund induce ectopic eye formation. This regulatory pathway, conserved among metazoans and the vertebrate homologues of eyeless (Pax6), sine oculis (Six1-6), eyes absent (Eya1-4), and dachshund (DACH1-2), contributes to organism development (Kawakami et al., 2000) . The six genes encode a conserved Six and Homeo domain sequencespecific DNA binding family of transcription factors. Eya functions as a coactivator for Six proteins, and functions in a phosphatase-dependent manner (Lee et al., 2000a) . The dachshund genes encode cointegrator proteins recruited to Six binding sites at the promoters of target genes that promote cellular differentiation and cell cycle exit. A conserved domain (dac and ski/sno domain 1), which has significant identity with Ski/Sno ([DS] domain), is conserved from Drosophila to the human (Chen et al., 1997; Davis et al., 1999; Kawakami et al., 2000) . The DACH1 protein binds the CBP coactivator or interacts directly with corepressors to regulate transcriptional activity (Ikeda et al., 2002; Li et al., 2003) . The recruitment of DACH1 to Six binding sites is regulated through mechanisms that have as yet to be defined.
In view of the finding that c-Jun plays a key role in oncogene-induced transformation and that DACH1 functions as an inhibitor of AP-1-responsive gene expression, we investigated the potential role for DACH1 in c-Jun-mediated cellular growth. DACH1 inhibited c-Jun-mediated DNA synthesis and contact-independent growth. AP-1 activity was repressed by DACH1 requiring a conserved ([DS]) domain. Repression of c-Jun transcription and transactivation by DACH1 required the DACH1 DS domain. DACH1 bound a corepressor complex, including HDAC1/HDAC3 and repressed c-Jun transactivation through the c-Jun ␦ domain. c-Jun transactivation and contact-independent growth is controlled by the cell fate determination factor DACH1.
MATERIALS AND METHODS

Plasmid Constructions
The expression plasmids that include an N-terminal FLAG peptide for DACH1, DACH1 DS-domain alone (DS), or DACH1 DS-domain deleted (⌬DS) were described previously (Wu et al., 2003) . The FLAG-tagged DACH1 c-DNA was subcloned into the MSCV-IRES-GFP and pLRT vector. The fulllength DACH1 cDNA was subcloned in frame with the VP16 activation domain in the pVP16 vector to form a DACH1-VP16 fusion protein. DACH1 short hairpin RNA (shRNA) in the pSM2 expression vector was purchased from Open Biosystems (Huntsville, AL) and subcloned into the LMP retroviral vector. The Ski cDNAs was subcloned into the 3x Flag-CMV7.1 vector (Sigma-Aldrich, St. Louis, MO). The expression vector encoding adenovirusinduced Cre expression or control viruses were described previously (Wang et al., 1995) . The cyclin A promoter (Katabami et al., 2005) and stathmin promoter (Kinoshita et al., 2003) reporter genes were described previously. The wt c-fos-LUC, serum response element (SRE), or ternary complex factor (TCF) mutants (PM12 and PM18) were described previously (Wang et al., 1998) . AP-1 Luc (3TPlux), c-Jun Luc and JunB Luc were described previously (Watanabe et al., 1996) . The expression vectors for c-Jun linked to Gal4 or E2 and truncated c-Jun were described previously (Baichwal and Tjian, 1990; Baichwal et al., 1991) . The Ha-Ras expression vector was described previously (Albanese et al., 1995) .
Cell Culture, DNA Transfection, and Luciferase Assays
Cell culture, DNA transfection, and luciferase assays were performed as described previously (Fu et al., 2000 (Fu et al., , 2002 (Fu et al., , 2003 . The NIH3T3, HEK293T, and MCF-7 cell line were cultured in DMEM supplemented with 10% fetal calf serum, 1% penicillin, and 1% streptomycin. c-jun fl/fl 3T3 cells were derived from mouse embryo fibroblast from c-jun fl/fl transgenic mouse by using the standard 3T3 protocol. Rat1a-J4 cells express c-Jun in a doxycycline-controlled manner (Katabami et al., 2005) . Cells were plated at a density of 1 ϫ 10 5 cells in a 24-well plate on the day before transfection with Superfect according to the manufacturer's protocol (QIAGEN, Valencia, CA). At least two different plasmid preparations of each construct were used. In cotransfection experiments, a dose response was determined in each experiment with 50 and 200 ng of expression vector and the promoter reporter plasmids (1 g). Luciferase activity was normalized for transfection by using ␤-galactosidase reporters as an internal control. Luciferase assays were performed at room temperature by using an Autolumat LB 953 (Berthold Technologies, Bad Wildbad, Germany). The -fold effect was determined for 50 -200 ng of expression vector with comparison made to the effect of the empty expression vector cassette and statistical analyses was performed using the Mann-Whitney U-test.
Small-interfering RNA (siRNA) Transfection, Western Blot, and Immunoprecipitation Assays
The Dach1 siRNA target sequence is 5Ј-AAAGTGGCTTCCTTTACGGTG. Control siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Dach1-specific siRNAs or control siRNAs (100 or 200 nM) were transfected following the Oligofectamine protocol (Invitrogen, Carlsbad, CA). Transfection efficiency was monitored by no-silencing fluorescein siRNA from QIAGEN. 3T3 cells were infected with DACH1 shRNA or control retrovirus and selected by puromycin. Western blot analysis using antibodies to c-Jun (Santa Cruz Biotechnology), cyclin A (Santa Cruz Biotechnology), ␤-PAK (Santa Cruz Biotechnology), E2 tag (Abcam, Cambridge, MA), FLAG tag (Sigma-Aldrich), and the loading control guanine dissociation inhibitor (GDI) was conducted as described previously (Lee et al., 2000b; Wu et al., 2003) . HEK293T cells were used for the detection of protein-protein interaction in vivo and immunoprecipitation was conducted as described previously using an anti-hemagglutinin (HA) antibody and immunoblotting with antibodies to HDAC1 (SC-7872), HDAC3 (SC-17795), NCoR (SC-8994), p300 (SC-585), and c-Jun (SC-44 and SC-1694).
Cell Cycle and DNA Synthesis Analysis
Cell cycle parameters were determined using laser scanning cytometry. Cells were processed by standard methods by using propidium iodide staining of cell DNA. Each sample was analyzed by flow cytometry with a FACScan flow cytometer (BD Biosciences, Mansfield, MA) by using a 488-nm laser. Histograms were analyzed for cell cycle compartments using ModFit version 2.0 (Verity Software House, Topsham, ME 
Cell Proliferation Assays
For the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, NIH3T3 cells infected with MSCV-IRES-GFP, MSCV-DACH1-IRES-GFP, or MSCV-DACH1⌬DS-IRES-GFP were seeded into 96-well plates in normal growth medium, and cell growth was measured every day by MTT bromide assays. c-Jun-expressing Rat1a-J4 cells were plated in growth medium in either the presence or absence of 2 g/ml doxycycline. To measure growth curve, cells were seeded into 12-well plates and serially counted for 5-6 d.
Colony Formation Assay
Rat1a-J4 cells (4.0 ϫ 10 3 ) were plated in triplicate in 3 ml of 0.3% agarose (sea plaque) in complete growth medium in the presence or absence of 2 g/ml doxycycline overlaid on a 0.5% agarose base, also in complete growth medium. Two weeks after incubation, colonies Ͼ50 m in diameter were counted using an Omnicon 3600 image analysis system. The colonies were visualized after staining with 0.04% crystal violet in methanol for 1-2 h.
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assays were performed as described previously (Fu et al., 2004) . Polymerase chain reaction (PCR) primers were as follows: for murine cyclin A: forward, 5Ј-CCTCAGGCTCCCGCCCTGTAAGATTCC and reverse, 5Ј-TCAAGTAGCCCGCGACTATTGAATAT; and for murine cyclin D1 AP-1 site: forward, 5Ј-CCGGTGGTCTGGTTCCTGGA and reverse, 5Ј-CCCCGAAA-ATTCCAGCAACA. The cells were cross-linked with formaldehyde buffer for 10 min at 37°C, and the procedure was followed as described in Fu et al. (2004) . Double ChIP assay was performed first using polyclonal c-Jun antibody, and then elution was diluted with 10X volume of immunoprecipitation (IP) buffer and then immune-precipitated with anti-FLAG M2 antibody following standard protocol.
RESULTS
c-Jun Is Required for DACH1-mediated Inhibition of Cellular Proliferation
To determine the role of Dachshund1 in fibroblast cellular proliferation and growth, NIH3T3 cells were transduced with a retroviral expression plasmid encoding DACH1 linked to green fluorescent protein (GFP) through an internal ribosomal entry site. Homogeneously transduced populations of NIH3T3 cells were compared with cells transduced with an empty expression vector (MSCV-IRES-GFP). DACH1 expression inhibited tritiated thymidine uptake by 75% ( Figure 1A ). To determine the domain of DACH1 involved in cellular proliferation, a mutation of the conserved DS domain was assessed. NIH3T3 cells transduced with the mutant DACH1 protein, which was expressed in equal amounts by Western blotting, failed to inhibit tritiated thymidine uptake ( Figure 1A ). Cellular proliferation assays were conducted by serial counting of cell number ( Figure  1B ) and the MTT stain ( Figure 1C ). Cells transduced with DACH1 failed to proliferate, whereas cells transduced with either a mutant DACH1 deleted of the DS domain or the GFP vector alone proliferated with similar efficiency. Fluorescence-activated cell sorting (FACS) analysis of DACH1-transduced NIH3T3 cells demonstrated an inhibition of DNA synthesis that was dependent upon the DS domain ( Figure 1D ). Expression of the DACH1 mutant, DACH1⌬DS was similar to the DACH1 wild type as assessed by Western blot analysis of the FLAG epitope at the N terminus of each protein ( Figure 1E ). Previous studies had shown AP-1 reporter activity was inhibited by DACH1 (Wu et al., 2003) . Endogenous AP-1 activity contributes to 3T3 cell proliferation. To examine the importance of c-Jun as an endogenous target of DACH1-mediated inhibition of DNA synthesis, we used c-jun-deficient 3T3 cells. c-jun Ϫ/Ϫ mice die in gestation from cardiovascular and hepatic defects (Eferl et al., 1999) . Significant functional differences have been observed in mouse embryonic fibroblasts derived from embryonic stem cell knockout, compared with cells derived by acute target gene excision by using floxed alleles and Cre recombinase (Sage et al., 2003) . We therefore derived c-jun fl/fl 3T3 cells from c-jun fl/fl mice by using a standard protocol (Todaro and Green, 1963) . The c-jun fl/fl 3T3 cells were transduced with Cre recombinase (Sage et al., 2003) , and the deletion of c-Jun was confirmed by Western blot analysis ( Figure 2A ). These cells were transduced with either a DACH1 retroviral expression vector or equal amount of control viral vector, and Western blot analysis and cellular proliferation assays were conducted. c-jun deletion was associated with a reduction in cyclin D1 and cyclin A expression consistent with prior findings that c-jun induces cyclin D1 and cyclin A (Albanese et al., 1995) . DACH1 expression in c-jun fl/fl cells reduced cyclin D1 abundance 30%, and cyclin A expression 50% ( Figure 2A ). DACH1 expression in parental c-jun fl/fl 3T3 cells reduced proliferation rates Ͼ35%. In cells deleted of c-jun (c-jun fl/fl ϩ Cre), expression of DACH1 failed to inhibit cellular proliferation ( Figure 2B ). A detailed time course was conducted to determine the role of c-jun in DACH1-mediated inhibition of cellular proliferation through daily counting of cells ( Figure 2C ). Cellular proliferation of wild-type cells was inhibited by DACH1 expression; however, the proliferation rate of cells deleted of c-jun was not affected by DACH1 expression ( Figure 2C ). To determine whether expression of c-Jun could overcome DACH1-mediated repression of cellular proliferation, a cell line encoding a doxycycline-inducible c-jun cDNA was used (3T3 Tet-c-Jun). The induction of c-Jun expression by the addition of doxycycline stimulated cellular proliferation ( Figure 2D ). Transduction of the NIH3T3 cells with DACH1 reduced cellular proliferation Ͼ60% at 6 d. Induction of c-Jun abundance, through the addition of doxycycline, restored cellular proliferation by Ͼ85% ( Figure 2E ). Together, these studies demonstrate DACH1 inhibition of cellular proliferation requires c-jun and can be overcome by c-Jun expression.
DACH1 Inhibits Colony Formation Requiring the Conserved DS Domain
The expression of c-Jun is sufficient to induce contact-independent growth of Rat1a cells (Schutte et al., 1989) . The stable cell line expressing doxycycline-inducible c-Jun was infected with an MSCV virus encoding either GFP, DACH1 wt or DACH1 mutant. Western blot analysis demonstrated the induction of c-Jun by doxycycline and transfected DACH1 protein was detected by an antibody directed to the N-terminal FLAG epitope ( Figure 3A ). DACH1 also inhibited basal proliferation of Rat1a-J4 cells ( Figure 3B ). Previous studies have demonstrated the importance of c-Jun in promoting cell cycle transition (Ryseck et al., 1988; Kovary and Bravo, 1991) . The c-Jun-induced thymidine uptake, reflecting DNA synthesis, was attenuated by DACH1 expression ( Figure 3C ). Colony formation was induced by c-Jun expression ( Figure 3D ) as described previously (Katabami et al., 2005) . Transduction of the inducible c-Jun stable cell line with a retroviral expression vector encoding DACH1 reduced the number of colonies by 40% ( Figure 3E ) and reduced the volume of individual colonies by Ͼ75% ( Figure  3F ). Expression of equal amount of a mutant DACH1 protein deleted of the DS domain (⌬DS) failed to inhibit c-Juninduced contact-independent growth ( Figure 3F ). Together, these results suggest that DACH1 inhibits c-Jun induced cellular proliferation and blocks c-Jun-mediated contactindependent growth. These results further suggest c-Jun is a key molecular target of DACH1 inhibition of contact-independent growth.
DACH1 Expression Inhibits Physiological Inducers of c-jun Expression and c-jun Target Gene Expression
The c-jun gene is induced by diverse physiological stimuli, including serum and growth factors. To determine whether DACH1 expression was capable of inhibiting the induction of c-Jun by physiological stimuli, NIH3T3 cells were treated with serum. Cells were transduced with retroviral expression vectors encoding either DACH1 or the DACH1 mutant (⌬DS). Consistent with prior studies, serum induced c-Jun abundance approximately Ͼ10-fold. The c-Jun target genes cyclin A and ␤-PAK were also induced by serum ( Figure 4A , lane l versus lane 2). NIH3T3 cells expressing DACH1 reduced serum-mediated expression of c-Jun by Ͼ50%. DACH1 expression reduced serum-induced expression of the c-Jun target genes cyclin A and ␤-PAK. Deletion of the DACH1 DS domain abrogated the DACH1-mediated inhibition of c-Jun, cyclin A, and ␤-PAK expression at 3 h. Expression of CDK4 and ␤-tubulin were unaffected by DACH1 expression, indicating the effect of DACH1, to inhibit c-Jun expression, is gene specific.
To examine further the mechanism by which DACH1 repressed the c-jun target gene cyclin A, we deployed the tetracycline-inducible c-jun stable Rat1a-J4 cell line ( Figure  4B ). Doxycycline addition induced c-Jun abundance, associated with the induction of the c-jun target genes cyclin A and ␤-PAK. Transduction of Rat1a-J4 cells with DACH1 abrogated c-Jun-mediated induction of cyclin A and ␤-PAK, c-jun target gene cyclin D1 (Albanese et al., 1995) was induced threefold and cyclin A was induced two-to fivefold ( Figure 4C ). Consistent with a key role for cyclin D1 in 3T3 cell DNA synthesis (Albanese et al., 2003) the DACH1 siRNA-mediated induction of cyclin D1 was associated with an induction of DNA synthesis determined by [ 3 H]thymidine uptake and S-phase distribution by FACS ( Figure 4C ).
To determine whether DACH1 directly regulated c-jun target genes, the cyclin A and stathmin promoters were assessed. Induction of c-Jun expression in the Rat1a-J4 cells by addition of doxycycline induced the activity of the cyclin A promoter activity fourfold ( Figure 4D ). Expression of DACH1 inhibited c-Jun-mediated induction of cyclin A promoter activity. Deletion of the DACH1 DS domain abolished the DACH1 repression function ( Figure 4D ). Similarly the stathmin promoter was induced by c-Jun, and c-Jun induction of the stathmin promoter was inhibited by DACH1, requiring the DACH1 DS domain ( Figure 4E ).
DACH1 Occupies the AP-1 Site of Endogenous c-Jun Target Genes in ChIP Assays
Because DACH1 repressed c-jun-mediated induction of several AP-1 target genes (Wu et al., 2003) , we sought to determine whether DACH1 occupied AP-1 sites of endogenous genes in the context of their local chromatin structure. For these studies, NIH3T3 cells were stably transduced with a FLAG-tagged DACH1 expression vector. The cyclin A promoter, a known c-Jun target gene, was examined. Using oligonucleotides directed to the endogenous murine cyclin A promoter AP-1/ATF-1 site, ChIP assays, conducted with the anti-FLAG antibody, demonstrated the presence of DACH1 in the context of the local chromatin structure of the endogenous cyclin A promoter ( Figure 5A ). Control IgG did not result in similar amplification. Analysis of the endogenous murine cyclin D1 AP-1 site by using oligonucleotides directed to the murine promoter demonstrated the presences of DACH1 at the cyclin D1 promoter AP-1 site ( Figure  5B ). The complex formation of c-Jun and Dach1 protein at the AP-1 site of the cyclin D1 promoter was further confirmed by sequential immune-precipitation with c-Jun and FLAG antibodies ( Figure 5C ). Further analysis of the endogenous proteins associated with DACH1 at the murine cyclin D1 promoter was conducted. Oligonucleotides directed to the murine cyclin D1 AP-1 site evidenced the presence of the DACH1-associated corepressor proteins HDAC1, HDAC3, mSin3A, and NCoR recruited to the murine cyclin D1 promoter ( Figure 5D ). To determine the role of the cyclin D1 promoter AP-1 site in recruitment of DACH1, ChIP assays were conducted comparing the wild-type and mutant cyclin D1 AP-1 site promoters ( Figure 5E ). Expression of FLAGtagged DACH1 enhanced recruitment of DACH1 (FLAG), together with HDAC1, HDAC3, mSin3A, and NCoR. Mutation of the cyclin D1 AP-1 site reduced recruitment of each of these proteins ( Figure 5E ). Immune-precipitation Western blot indicated these proteins form a cellular complex (Figure 5F ).
DACH1 Inhibition of AP-1 Family Members
To determine the domains of DACH1 involved in inhibiting c-Jun function, an AP-1-responsive reporter gene (3TP-LUX) was assessed in HEK293T cells. The activity of the AP-1 reporter gene was inhibited by DACH1 expression ( Figure  6A ). The deletion of the DACH1 DS domain abrogated repression of AP-1 reporter activity, and the DS domain alone was insufficient for repression of AP-1 activity ( Figure  6A) . We assessed the effect of DACH1 on the transcriptional activity of the key AP-1 genes, c-jun, junB, and c-fos. The transcriptional activity of the c-Jun promoter was repressed by DACH1 expression, and this transcriptional repression was abrogated by the deletion of the conserved DS domain ( Figure 6B ). Similarly, the junB and c-fos promoters were repressed by DACH1 expression, and the DS domain was required for repression ( Figure 6, C and D) .
AP-1 activity is serum inducible, and serum induction of the c-jun promoter was inhibited by DACH1 expression ( Figure 6E) . Similarly, the c-fos promoter induction by serum was inhibited by DACH1 expression ( Figure 6F ). DACH1 shares homology with Ski (Kozmik et al., 1999) . To determine whether Ski functions as a transcriptional repressor of c-fos or c-jun promoter activity, serum induction experiments were conducted. Ski expression failed to repress serum-induced c-jun and c-fos promoter activity ( Figure 6G) . Thus, c-fos was repressed by DACH1 and not by Ski. Together, these results demonstrate distinct transcriptional repression profiles of DACH1 and the related Ski protein.
We examined further the DNA sequences of the c-fos promoter required for transcriptional repression by DACH1. A point mutant of the SCF binding site and the TCF binding site of the c-fos promoter were compared ( Figure 7A ). Consistent with previous findings (Hill et al., 1995) , mutation of either the c-fos SRE or TCF binding site reduced seruminduced activation of the c-fos promoter ( Figure 7B ). The c-fos promoter encoding a point mutation of either the SRE or the TCF site was compared for repression by DACH1. DACH1 repressed activity of the c-fos promoter, encoding a mutation of the TCF site (c-fos PM18) ( Figure 7C ). In contrast, point mutation of the SRE binding site (c-fos PM12) abrogated repression by DACH1, inducing transactivation rather than repression by DACH1 ( Figure 7D ). These results demonstrate the SRE site of the c-fos promoter is a transcriptional target of DACH1 repression in 3T3 cells. To determine whether these effects were similar in other cell types, MCF-7 cells were assessed. The c-fos promoter was activated sixfold by 12-O-tetradecanoylphorbol-13-acetate (TPA) ( Figure 7E ). Point mutation of either the TCF or SRE site of the c-fos promoter reduced activation by TPA. Consistent with findings in NIH3T3 cells, DACH1 repressed the c-fos promoter and point mutation of the SRE site abrogated repression ( Figure 7F ). Collectively, these experiments demonstrate DACH1 inhibits the physiological induction of the promoters encoding AP-1 response genes, including c-jun, junB, and c-fos. The mechanism by which DACH1 inhibits gene expression is distinct from the related protein Ski.
DACH1 Inhibition of c-Jun Transactivation Requires the ␦ Domain
To examine further the mechanisms by which DACH1 inhibited c-Jun transactivation, mammalian two-hybrid studies were undertaken. (Baichwal and Tjian, 1990) . The heterologous transactivation domains of c-Jun linked to the E2 DNA binding domain were assessed using a multimeric E2 DNA binding domain, linked to a luciferase reporter gene ( Figure 8A ). The wild-type and mutant chimeric c-Jun proteins were expressed equally in DACH1-transfected cells ( Figure 8B) . Activity of the c-Jun protein was enhanced by oncogenic Ras (Ha-RasV12) consistent with previous findings that Ras alleviates repression of a c-Jun inhibitor (Baichwal et al., 1991) . DACH1 expression inhibited c-Jun transactivation by Ha-RasV12 ( Figure  8C ). To determine the domains of c-Jun repressed by DACH1, comparison were made between c-Jun and the mutant c-Jun proteins. c-Jun E2 activity was repressed by DACH1 in a dose-dependent manner. In contrast, the del ␦ c-Jun and v-Jun activities were not repressed by DACH1 ( Figure 8D ). To determine the role of endogenous DACH1 as an inhibitor of c-jun transactivation function, DACH1 shRNA was used in 3T3 cells. The transactivation function of c-jun was enhanced by expression of DACH1 shRNA (Figure 8E) . Activity of both the c-Jun protein deleted of the ␦ domain and v-Jun was constitutively more active than the corresponding c-Jun protein, and they were unaffected by depletion of DACH1 abundance ( Figure 8E ). Similarly, shRNA expression to DACH1 enhanced AP-1 activity using on AP-1-responsive reporter gene ( Figure 8F ). These findings suggest the ␦ domain of c-Jun is required for endogenous DACH1 repression of c-Jun transactivation activity.
To examine further the mechanisms by which DACH1 repressed oncogenic Ras-induced activity of c-Jun, a series of Gal4-c-Jun expression vectors were used (Baichwal and Tjian, 1990) (Figure 9A ). The interaction between DACH1 and c-Jun was assessed using a mammalian two-hybrid system, and activity of c-Jun was determined using a multimeric Gal4 DNA binding site linked to a luciferase reporter gene ( Figure 9B ). VP16-DACH1 demonstrated no functional interaction with the Gal4-DBD. Cointroduction of VP16-DACH1 enhanced transactivation with Gal4-c-Jun, indicating functional interaction between DACH1 and c-Jun and the induction of transactivation by the recruitment of the potent acidic transactivation surface of VP-16 to the minimal E1B promoter. Thus, DACH1 functionally interacts with c-Jun in a mammalian two-hybrid assay ( Figure 9B) . To determine the effect of DACH1 expression on c-Jun activity, DACH1 was coexpressed with an expression vector encoding Gal4-c-Jun 5-253 and c-Jun activity determined using luciferase reporter activity. DACH1 repressed Gal4-c-Jun activity ( Figure 9C ). The DACH1 mutant ⌬DS, however, was incapable of repressing Gal4-c-Jun activity ( Figure 9C ). These findings are consistent with the previous studies, in which DACH1 inhibition of AP-1 activity required the DS domain. The activity of Gal4-c-Jun was enhanced by oncogenic Ras, however, deletion of amino acids 1-139 abrogated Ras-induced transactivation ( Figure 9D ), consistent with previous findings (Baichwal et al., 1991) . DACH1 inhibited c-Jun activation by Ras ( Figure 9E ). Together, these results demonstrate, first, that DACH1 inhibits oncogenic Ras-induced transactivation of c-Jun; second, that DACH1 associates with and inhibits c-Jun activity; third, that physical association of DACH1 with c-Jun is necessary but insufficient for repression; and fourth, that the c-Jun ␦ domain is required for DACH1 repression.
To examine further the mechanisms by which DACH1 represses c-Jun, we compared the properties of DACH1-mediated repression of c-Jun, with the properties of a previously described inhibitor of c-Jun. Previous studies using in vivo competition assays identified an inhibitor of c-Jun activity (Baichwal and Tjian, 1990; Baichwal et al., 1991) . In these prior studies, coexpression of the mammalian expression vector encoding either the wild-type or mutant c-Jun was used to identify the domains of c-Jun required for interaction with the ␦ domain inhibitory factor (Baichwal and Tjian, 1990; Baichwal et al., 1991) . In our experiments, the ability of DACH1 to repress activity of c-Jun-E2 was overcome by c-Jun expression in trans ( Figure 10A , lane 3 versus lane 5). To determine the domains of c-Jun capable of binding DACH1, immunoprecipitation Western blot analysis were conducted using truncated or mutant c-Jun ( Figure  10B or mutated of either the DNA binding or dimerization domains remained capable of binding DACH1 ( Figure 10C ). Mutated of either the DNA binding domain or the dimerization domain, each rescued DACH1 repression. But deletion of the amino-terminal 91 amino acids (N91) and A2 domain resulted in a mutant that failed to overcome DACH1 repression ( Figure 10D ). Together, these findings are consistent with a model in which DACH1 repression involves an interaction in trans, which requires the c-Jun ␦ and A2 domains but is independent of the c-Jun dimerization and DNA binding domains. DACH1 binding to c-Jun is insufficient for repression as DACH1 bound a c-Jun mutant deleted of the A2 domain; yet, this mutant failed to rescue DACH1 repression in trans. Together, these findings indicated the c-Jun ␦ and A2 domains interact in trans to mediate DACH1 repression of c-Jun.
DISCUSSION
In the current study, DACH1 inhibited DNA synthesis and cellular proliferation in 3T3 cells. Deletion of the c-Jun gene by using c-jun fl/fl 3T3 cells and Cre recombinase demonstrated a requirement for c-Jun in DACH1-mediated inhibition of cellular proliferation. c-Jun overexpression rescued DACH1-mediated inhibition of DNA synthesis. c-Jun promotes G 1 phase progression and c-Jun is necessary for G 0 / G 1 -and S-phase progression (Ryseck et al., 1988; Kovary and Bravo, 1991) . The finding that DACH1 inhibited the DNA synthetic phase of the cell cycle is consistent with the known role of c-Jun to promote G 1 /S-phase transition. The mechanism by which DACH1 inhibited c-Jun expression involved inhibition of AP-1 activity. c-Fos and c-Jun, which contribute to AP-1 activity, were transcriptionally repressed by DACH1. c-Jun abundance is regulated in part by c-Jun gene transcription (Angel et al., 1988; Treier et al., 1994; Fuchs et al., 1996; Musti et al., 1997) . The c-Jun promoter, which is autoregulated by AP-1 activity mediated through an AP-1 binding site (Angel et al., 1988; Kayahara et al., 2005) was repressed by DACH1. Thus, c-Jun expression and transcription were both inhibited by DACH1.
The current study identifies DACH1 as a c-Jun repressor protein, extending prior observations that c-Jun binds JDP1 and JDP2 (Piu et al., 2001) . Recent studies using genomewide microarray analysis suggested a potential new mechanism controlling AP-1 activity (Wu et al., 2003) . In these studies, inducible expression of the cell fate determination factor DACH1 inhibited expression of the genes governing cellular migration, adhesion, and growth, many of which are AP-1 responsive (Wu et al., 2003) . The abundance and activity of c-Jun is a critical determinant of tumor progression and contact independent growth. Compelling evidence for a key role of c-Jun in tumor progression was the finding that disruption of the c-jun gene in murine hepatocytes prevents the emergence of hepatocellular carcinoma . DACH1 repression of c-Jun expression provides an additional mechanism controlling c-Jun abundance and function. DACH1 protein is lost during tumor progression, providing a mechanism by which c-Jun activity may be increased, contributing to contact-independent growth. Thus, the current study suggests an additional mechanism by which c-Jun transformation function is kept in check through the endogenous inhibitory protein DACH1. c-Jun is sufficient for the induction of anchorage-independent growth of Rat1a cells (Schutte et al., 1989; Katabami et al., 2005) . Herein, c-Jun-induced contact-independent growth was blocked by the cell fate determination factor DACH1. DACH1 inhibition of c-Jun-induced cellular growth required a conserved domain (DS domain). c-Jun acts in conjunction with Ras-V12 to transform rodent fibroblasts (Alani et al., 1991; Binetruy et al., 1991) . c-Jun is required for transformation by several collaborative oncogenes, including Ras, c-Fos, Raf, c-Myc, Mos, and Abl (Rapp et al., 1994; Johnson et al., 1996) . The finding that DACH1 blocks c-Jun function raises the possibility that DACH1 may inhibit multiple distinct oncogenic signaling pathways that converge on c-Jun. The mechanism by which c-Jun induces cellular growth and tumor progression is not well understood (Maeda and Karin, 2003) . It has been proposed that c-Jun contributes to the onset and progression of tumorigenesis, in part through c-Jun inhibition of apoptosis via a p53-dependent cellular pathway . The defect in proliferation of c-jun-deficient cells has been attributed to elevated expression of p53 and p21 CIP1 , and several downstream targets of c-Jun are required, but not sufficient, for induction of contact-independent growth, including stathmin, HMG 1/Y, and cyclin A (Kinoshita et al., 2003; Hommura et al., 2004; Katabami et al., 2005) . DACH1 inhibited the physiological induction by serum of the c-Jun target genes cyclin A and ␤-PAK. The expression of c-Jun with a doxycycline-inducible stable cell line (Rat1a-J4) induced expression of cyclin A. DACH1 inhibited c-Jun induction of cyclin A expression. DACH1 inhibited c-Jun-mediated induction of several known endogenous c-Jun target genes, including cyclin A and stathmin; and DACH1 was identified within the context of local chromatin of the endogenous AP-1 sites at the known c-Jun-responsive promoter of cyclin A and cyclin D1. DACH1 siRNA reduced DACH1 abundance and induced expression of the c-Jun responsive genes c-Jun and cyclin D1. Collectively, these studies demonstrate that In the current studies, DACH1 repression of c-Jun required the c-Jun ␦ domain. Activity of the v-Jun E2 fusion protein, which deletes the ␦ domain, was resistant to DACH1 repression. The c-Jun ␦ domain engages cell-specific inhibitors of c-Jun (Baichwal and Tjian, 1990) . Putative inhibitors of this domain include catalytically inactive JNK (Dai et al., 1995; Ljungdahl et al., 1997) . JNK binds and phosphorylates c-Jun at serine 63 and 73. The role of the ␦ domain itself versus JNK phosphorylation within the N terminus of c-Jun for cellular DNA synthesis and transformation remains controversial. C-Jun promotion of G 1 phase progression seems to be independent of its phosphorylation (Wisdom et al., 1999) . The JNK binding site of c-Jun can also be uncoupled from its transformation capabilities in same studies (Sprowles and Wisdom, 2003) . Thus, mutation of the JNK phosphorylation sites did not affect the transformation activity of c-Jun in chicken embryo fibroblasts (Vogt, 2001 ). Furthermore, JNK-dependent phosphorylation of the c-Jun N terminus may not be required for Ras-induced cellular transformation (Johnson et al., 1996; Kennedy et al., 2003) . In contrast with these studies, mice and cells encoding a mutant allele of c-jun in which the JNK phosphorylation site has been mutated demonstrated an important role for these residues in c-jun-dependent transformation (Behrens et al., 2000) . Furthermore, although mutation of serine 63 and 73 in v-Jun did not alter transforming activity of v-jun, mutation of these residues in c-jun reduced cooperation with Ha-Ras in oncogenic transformation . The current study is consistent with a role for DACH1 as an inhibitor of the c-Jun ␦ domain.
The transactivation potential of c-Jun and its oncogenic activity in cooperation with Ras are often correlated (Alani et al., 1991; Smeal et al., 1991) , although exceptions exist in avian and yeast systems (Vogt, 2001 ). In the current study, DACH1 inhibited c-Jun-mediated transactivation. DACH1 binding to the N-terminal domain of c-Jun may repress c-Jun activity by recruiting a corepressor or interfering with coactivator binding. CBP binds to the N-terminal region of c-Jun (Bannister et al., 1991; Mayr and Montminy, 2001) as does RH2/Gu-RNA-helicase (Westermarck et al., 2002) . The corecruitment of histone deacetylase proteins HDAC1 and HDAC3 by DACH1, to c-Jun and thereby to an AP-1 binding site, provides one mechanism by which DACH1 may regulate AP-1 signaling. Recent studies suggested that the c-Jun ␦ domain may interact with a yet unidentified protein that recruits HDAC3 (Weiss et al., 2003) . The relative importance of DACH1 in recruitment of histone deacetylase to c-Jun remains to be further explored.
Herein, DACH1 repressed the c-fos promoter. DACH1 transcriptional repression was abolished by point mutation of the SRE site. In the current study, serum-induced c-fos promoter activity was reduced by point mutation in either the TCF or SRE binding site. Extracellular stimuli enhance TCF transcriptional activity through the MAPK family of extracellular regulated kinases (extracellular signal-regulated kinases, JNKs, and p38s), which phosphorylate the TCF transactivation domain (Whitmarsh et al., 1995 (Whitmarsh et al., , 1997 . The SRF site of the c-fos promoter is induced by RhoA independently of MAPKs (Sotiropoulos et al., 1999; Miralles et al., 2003) . RhoA induction of SRF involves ROCK and phosphorylation of LIM kinase (Hill et al., 1995) . Activation of SRF involves a decrease in the cellular pool of monomeric actin (Sotiropoulos et al., 1999) . LIM kinase-dependent phosphorylation of cofilin induces the stabilization of polymerized actin (F-actin), which is sensed by SRF to induce its activity (Sotiropoulos et al., 1999; Miralles et al., 2003) . DACH1 regulates cytoskeletal proteins and their function as evidenced by genome-wide analysis of molecular genetic targets (Wu et al., 2003) . Although speculative, the finding that DACH1 inhibits c-fos promoter activity through the SRF site is consistent with a role for DACH1 in regulating a RhoA/ROCK/LIM kinase cytoskeletal signaling pathway.
